GLP-1 Medicines: Impact on Women's Reproductive Health, Fertility, and Pregnancy

• GLP-1 medicines, used for weight management, can influence women's reproductive health due to their metabolic effects.
• Improved insulin sensitivity and weight reduction from GLP-1 therapy can indirectly enhance fertility, especially for women with PCOS, by stabilizing hormonal levels.
• Women may experience temporary changes in menstrual cycles due to rapid weight loss and hormonal shifts; persistent irregularities require medical evaluation.
• Increased fertility due to GLP-1 therapy raises the risk of unplanned pregnancy, making contraception counseling crucial.
• GLP-1 medicines are not recommended during pregnancy, and women planning conception should discontinue them with an adequate washout period.

Why It Matters: GLP-1 medicines significantly impact women's reproductive health, requiring careful consideration for fertility and pregnancy.